InsiderTrades.com logo

BLSM Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $25,181,900.00
Insider Selling (Last 12 Months): $0.00

BlossomHill Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at BlossomHill Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BlossomHill Therapeutics Share Price & Price History

Current Price: $22.01
Price Change: ▲ Price Increase of +1.99 (9.94%)
As of 09/4/2026 04:00 PM ET

This chart shows the closing price history over time for BLSM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BlossomHill Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2026Bihua ChenDirectorBuy312,500$16.00$5,000,000.003,614,034View SEC Filing Icon  
8/10/2026Carl L. GordonDirectorBuy625,000$16.00$10,000,000.002,714,279View SEC Filing Icon  
8/10/2026Jason A. KeyesCFOBuy700$16.00$11,200.00700View SEC Filing Icon  
8/10/2026John P SchmidDirectorBuy6,000$16.00$96,000.006,000View SEC Filing Icon  
8/10/2026Orbimed Advisors LlcDirectorBuy625,000$16.00$10,000,000.002,714,279View SEC Filing Icon  
8/10/2026Vincent Paul LiptakGeneral CounselBuy2,200$16.00$35,200.00111,412View SEC Filing Icon  
8/7/2026Vincent Paul LiptakGeneral CounselBuy2,500$15.80$39,500.00109,212View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BlossomHill Therapeutics (NASDAQ:BLSM)

BlossomHill Therapeutics logo
BlossomHill Therapeutics Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop small molecule medicines which address significant unmet medical needs in cancer treatment. The company's lead clinical programs include BH-30643. BlossomHill Therapeutics Inc. is headquartered in San Diego, California.
Read More on BlossomHill Therapeutics

Today's Range

Now: $22.01
Low: $19.36
High: $22.16

50 Day Range

MA: N/A

52 Week Range

Now: $22.01
Low: $15.25
High: $22.16

Volume

168,442 shs

Average Volume

290,737 shs

Market Capitalization

$674.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of BlossomHill Therapeutics?

BlossomHill Therapeutics' top insider investors include:
  1. Bihua Chen (Director)
  2. Carl L Gordon (Director)
  3. Orbimed Advisors Llc (Director)
  4. Vincent Paul Liptak (General Counsel)
  5. John P Schmid (Director)
  6. Jason A Keyes (CFO)
Learn More about top insider investors at BlossomHill Therapeutics.

BlossomHill Therapeutics Active Insiders

Jason A Keyes
Jason A Keyes
Executive Vice President and Chief Financial Officer
1 recent trades
Vincent Paul Liptak
Vincent Paul Liptak
Executive Vice President and General Counsel
2 recent trades
Bihua Chen
Bihua Chen
Director
1 recent trades
Carl L Gordon
Carl L Gordon
Director
1 recent trades